HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CymaBay Therapeutics (CBAY) Investors Who Have Suffered Losses to Contact its ...
SAN FRANCISCO, March 09, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges investors in CymaBay Therapeutics, Inc. (NASDAQ: CBAY) who have suffered significant losses to submit their losses now. The firm is investigating possible securities law violations, and …